Erlend Aune
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erlend Aune has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Jan Erik Otterstad
4 shared publications- Jan Erik Otterstad
Department of Cardiology, Vestfold Hospital Trust, Tønsberg, Norway
4 shared publications - Jo Røislien
Department of Quality and Health Technology, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway
4 shared publications Knut Endresen
Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway
3 shared publications- Daesoo Lee
Norwegian University of Science and Technology Norwegian University of Science and Technology BI Norwegian Business School Norwegian Seismic Array Norwegian University of Science and Technology
2 shared publications Jon Erik Steen-Hansen
Prehospital Clinic, Vestfold Hospital Trust, Toensberg, Norway
2 shared publications
Latest Publications
- 1 May 2026
- Published by Springer Nature
- p. 61-74
Closing the Gap Between Synthetic and Ground Truth Time Series Distributions via Neural Mapping
- 1 May 2026
- Published by Springer Nature
- p. 61-74
Closing the Gap Between Synthetic and Ground Truth Time Series Distributions via Neural Mapping
- Open Access
- 26 July 2024
- Published by Elsevier in Pattern Recognition
- Vol. 156
Explainable time series anomaly detection using masked latent generative modeling
- 26 July 2024
- Published by Elsevier in Pattern Recognition
- Vol. 156
Open AccessExplainable time series anomaly detection using masked latent generative modeling
- Open Access
- 23 August 2011
- Published by Springer Nature in BMC Medicine
- Vol. 9 (1) , 97
The "smoker's paradox" in patients with acute coronary syndrome: a systematic review
Smokers have been shown to have lower mortality after acute coronary syndrome than non-smokers. This has been attributed to the younger age, lower co-morbidity, more aggressive treatment and lower risk profile of the smoker. Some studies, however, have used multivariate analyses to show a residual survival benefit for smokers; that is, the "smoker's paradox". The aim of this study was, therefore, to perform a systematic review of the literature and evidence surrounding the existence of the "smoker's paradox".
- 23 August 2011
- Published by Springer Nature in BMC Medicine
- Vol. 9 (1) , 97
Open AccessThe "smoker's paradox" in patients with acute coronary syndrome: a systematic review
Smokers have been shown to have lower mortality after acute coronary syndrome than non-smokers. This has been attributed to the younger age, lower co-morbidity, more aggressive treatment and lower risk profile of the smoker. Some studies, however, have used multivariate analyses to show a residual survival benefit for smokers; that is, the "smoker's paradox". The aim of this study was, therefore, to perform a systematic review of the literature and evidence surrounding the existence of the "smoker's paradox".
- Open Access
- 15 December 2010
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 10 (1) , 59
The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction
The aim of the present study was to investigate whether a previously shown survival benefit resulting from routine early invasive management of unselected patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) may differ according to smoking status and age.
- 15 December 2010
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 10 (1) , 59
Open AccessThe effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction
The aim of the present study was to investigate whether a previously shown survival benefit resulting from routine early invasive management of unselected patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) may differ according to smoking status and age.
- 1 January 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (1) , 36-42
Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction
- 1 January 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (1) , 36-42
Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction
- Open Access
- 6 July 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 35
The limited usefulness of real-time 3-dimensional echocardiography in obtaining normal reference ranges for right ventricular volumes
To obtain normal reference ranges and intraobserver variability for right ventricular (RV) volume indexes (VI) and ejection fraction (EF) from apical recordings with real-time 3-dimensional echocardiography (RT3DE), and similarly for RV area indexes (AI) and area fraction (AF) with 2-dimensional echocardiography (2DE).
- 6 July 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 35
Open AccessThe limited usefulness of real-time 3-dimensional echocardiography in obtaining normal reference ranges for right ventricular volumes
To obtain normal reference ranges and intraobserver variability for right ventricular (RV) volume indexes (VI) and ejection fraction (EF) from apical recordings with real-time 3-dimensional echocardiography (RT3DE), and similarly for RV area indexes (AI) and area fraction (AF) with 2-dimensional echocardiography (2DE).
- 12 May 2009
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 10 (6) , 738-744
Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography
The aim of this study was to obtain normal reference ranges and intra-observer reproducibility for left (L) and right (R) atrial (A) volume indexes (VI, corrected for body surface area) and ejection fractions (EF) with real-time three-dimensional echocardiography. One hundred and sixty-six participants, 79 males and 87 females, aged 29-79 years considered free from clinical and subclinical cardiovascular disease, were included. Normal ranges are defined as 95% reference values for atrial dimensions and reproducibility as coefficients of variations (CVs) for repeated measurements. Upper normal reference values were 41 mL/m(2) for maximum (max) LAVI and 19 mL/m(2) for minimum (min) LAVI. The lower normal reference value was 45% for LAEF. The respective values for RA were 47 mL/m(2), 20 mL/m(2), and 46%. The only relevant gender difference was a higher upper normal max RAVI among males vs. females. The CVs for repeated measurements were 9% for max LAVI, 8% for max RAVI, 13% for LAEF, and 14% for RAEF. The present study provides normal ranges for atrial dimensions and contractility with a new, fast, and reproducible technique that can be used bedside without offline analysis.
- 12 May 2009
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 10 (6) , 738-744
Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography
The aim of this study was to obtain normal reference ranges and intra-observer reproducibility for left (L) and right (R) atrial (A) volume indexes (VI, corrected for body surface area) and ejection fractions (EF) with real-time three-dimensional echocardiography. One hundred and sixty-six participants, 79 males and 87 females, aged 29-79 years considered free from clinical and subclinical cardiovascular disease, were included. Normal ranges are defined as 95% reference values for atrial dimensions and reproducibility as coefficients of variations (CVs) for repeated measurements. Upper normal reference values were 41 mL/m(2) for maximum (max) LAVI and 19 mL/m(2) for minimum (min) LAVI. The lower normal reference value was 45% for LAEF. The respective values for RA were 47 mL/m(2), 20 mL/m(2), and 46%. The only relevant gender difference was a higher upper normal max RAVI among males vs. females. The CVs for repeated measurements were 9% for max LAVI, 8% for max RAVI, 13% for LAEF, and 14% for RAEF. The present study provides normal ranges for atrial dimensions and contractility with a new, fast, and reproducible technique that can be used bedside without offline analysis.
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- p. 1-7
Reference values for left ventricular volumes with real-time 3-dimensional echocardiography
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- p. 1-7
Reference values for left ventricular volumes with real-time 3-dimensional echocardiography
- Open Access
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 40 (3) , 137-144
High mortality rates in conservatively managed patients with acute coronary syndrome
The revised diagnostic criteria for the acute coronary syndrome (ACS) have created the need for accurate and representative data on treatment and outcome for the three categories of ACS. Consecutive patients admitted with a suspected ACS (n = 755) from February 1, 2003 to January 31, 2004 was registered and categorised into five diagnostic groups: 1) ST-elevation myocardial infarction (STEMI) (n = 126), 2) Non-ST-elevation myocardial infarction (NSTEMI) (n = 185), 3) Unstable angina pectoris (UAP) (n = 55), 4) Coronary heart disease (CHD) without ACS (n = 164) and 5) Non-coronary chest pain (n = 225). All-cause one-year mortality rates were 20%, 32%, 7%, 10% and 3%, in patients with STEMI, NSTEMI, UAP, CHD without ACS and non-coronary chest pain, respectively. In patients with STEMI, 61% received immediate reperfusion therapy (ratio thrombolysis: primary PCI = 18:1). Only 3% of those with NSTEMI had PCI within two days. In this conservatively managed population of consecutive patients with ACS, the one-year mortality rate is significantly higher than seen in most registries and clinical trials.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 40 (3) , 137-144
Open AccessHigh mortality rates in conservatively managed patients with acute coronary syndrome
The revised diagnostic criteria for the acute coronary syndrome (ACS) have created the need for accurate and representative data on treatment and outcome for the three categories of ACS. Consecutive patients admitted with a suspected ACS (n = 755) from February 1, 2003 to January 31, 2004 was registered and categorised into five diagnostic groups: 1) ST-elevation myocardial infarction (STEMI) (n = 126), 2) Non-ST-elevation myocardial infarction (NSTEMI) (n = 185), 3) Unstable angina pectoris (UAP) (n = 55), 4) Coronary heart disease (CHD) without ACS (n = 164) and 5) Non-coronary chest pain (n = 225). All-cause one-year mortality rates were 20%, 32%, 7%, 10% and 3%, in patients with STEMI, NSTEMI, UAP, CHD without ACS and non-coronary chest pain, respectively. In patients with STEMI, 61% received immediate reperfusion therapy (ratio thrombolysis: primary PCI = 18:1). Only 3% of those with NSTEMI had PCI within two days. In this conservatively managed population of consecutive patients with ACS, the one-year mortality rate is significantly higher than seen in most registries and clinical trials.
- 8 September 2005
- Vol. 125 (17) , 2342-4
[Referral to elective and emergency coronary investigation from a medium-size central hospital].
Little is known about regional differences in the incidence of acute and elective invasive coronary procedures in Norway. Such information is important in the planning of new invasive centres. In this prospective study all patients referred to coronary angiography at the Rikshospitalet University Hospital in Oslo (100 km remote) from the county of Vestfold (218,000 inhabitants) from 1 December 2002 to 30 November 2003 were included. Referrals were categorised as acute or elective. Based upon the discharge summaries from Oslo, all coronary angiographies, percutaneous interventions and coronary artery bypass grafts were registered. A total of 760 patients were referred, of whom 746 (98 %) underwent coronary angiography (19 % acutely). They were treated as follows: percutaneous coronary intervention, n = 295 (31 % acutely); coronary artery bypass grafting, n = 123 and conservative treatment, n = 342. Based upon these results, the incidence figures for 100,000 inhabitants per year in 2003 were similar to the nation-wide average for percutaneous interventions per year in Norway in 2001 and approximately 30 % below that average for 2003. Therefore, in the planning of an optimal peripheral catheterisation laboratory, the population basis has to be calculated from the local incidence of procedures, since there are obviously significant regional differences in the use of such procedures.
- 8 September 2005
- Vol. 125 (17) , 2342-4
[Referral to elective and emergency coronary investigation from a medium-size central hospital].
Little is known about regional differences in the incidence of acute and elective invasive coronary procedures in Norway. Such information is important in the planning of new invasive centres. In this prospective study all patients referred to coronary angiography at the Rikshospitalet University Hospital in Oslo (100 km remote) from the county of Vestfold (218,000 inhabitants) from 1 December 2002 to 30 November 2003 were included. Referrals were categorised as acute or elective. Based upon the discharge summaries from Oslo, all coronary angiographies, percutaneous interventions and coronary artery bypass grafts were registered. A total of 760 patients were referred, of whom 746 (98 %) underwent coronary angiography (19 % acutely). They were treated as follows: percutaneous coronary intervention, n = 295 (31 % acutely); coronary artery bypass grafting, n = 123 and conservative treatment, n = 342. Based upon these results, the incidence figures for 100,000 inhabitants per year in 2003 were similar to the nation-wide average for percutaneous interventions per year in Norway in 2001 and approximately 30 % below that average for 2003. Therefore, in the planning of an optimal peripheral catheterisation laboratory, the population basis has to be calculated from the local incidence of procedures, since there are obviously significant regional differences in the use of such procedures.